For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Podcast archive view
Vault Navigation
Podcast archive
Collection of podcasts created by New Zealand Doctor along with links to other podcasts of interest to our readers
New Zealand Doctor Rata Aotearoa editor Barbara Fountain talks to Stephen McKernan, director of the Health and Disability Review Transition Unit, and his deputy, Martin Hefford, about function trumping form, a crucial health plan, central agencies vs local services, communities and localities, private providers, workforce, leadership and, ultimately, selling the plan for health sector reform and convincing people to stay the course...
New Zealand Doctor Rata Aotearoa editor Barbara Fountain talks to David Meates, former chief executive of Canterbury DHB and now roving health reform consultant, about how change happens in health systems…and more